127 related articles for article (PubMed ID: 14756439)
1. Matrix metalloproteinase-2 and -9 expression in astrocytic tumors.
Kunishio K; Okada M; Matsumoto Y; Nagao S
Brain Tumor Pathol; 2003; 20(2):39-45. PubMed ID: 14756439
[TBL] [Abstract][Full Text] [Related]
2. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
3. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
[TBL] [Abstract][Full Text] [Related]
5. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Thorns V; Walter GF; Thorns C
Anticancer Res; 2003; 23(5A):3937-44. PubMed ID: 14666700
[TBL] [Abstract][Full Text] [Related]
6. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.
Komatsu K; Nakanishi Y; Nemoto N; Hori T; Sawada T; Kobayashi M
Brain Tumor Pathol; 2004; 21(3):105-12. PubMed ID: 15696970
[TBL] [Abstract][Full Text] [Related]
7. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
9. [Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].
Wang J; Liu YS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):647-50. PubMed ID: 16114548
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
Stojic J; Hagemann C; Haas S; Herbold C; Kühnel S; Gerngras S; Roggendorf W; Roosen K; Vince GH
Neurosci Res; 2008 Jan; 60(1):40-9. PubMed ID: 17980449
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Annexin A1 and its correlation with matrix metalloproteinases and the receptor for formylated peptide-2 in diffuse astrocytic tumors.
Tadei MB; Mayorquim MV; de Souza CB; de Souza Costa S; Possebon L; Souza HR; Iyomasa-Pilon MM; Geromel MR; Girol AP
Ann Diagn Pathol; 2018 Dec; 37():62-66. PubMed ID: 30286327
[TBL] [Abstract][Full Text] [Related]
12. Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors.
Takano S; Tsuboi K; Matsumura A; Tomono Y; Mitsui Y; Nose T
J Cancer Res Clin Oncol; 2000 Mar; 126(3):145-52. PubMed ID: 10741908
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
[TBL] [Abstract][Full Text] [Related]
14. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
[TBL] [Abstract][Full Text] [Related]
15. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
Kato Y; Yamashita T; Ishikawa M
Oncol Rep; 2002; 9(3):565-9. PubMed ID: 11956628
[TBL] [Abstract][Full Text] [Related]
16. Patched and smoothened mRNA expression in human astrocytic tumors inversely correlates with histological malignancy.
Katayam M; Yoshida K; Ishimori H; Katayama M; Kawase T; Motoyama J; Kamiguchi H
J Neurooncol; 2002 Sep; 59(2):107-15. PubMed ID: 12241103
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas.
Okada M; Miyake K; Matsumoto Y; Kawai N; Kunishio K; Nagao S
J Neurooncol; 2004 Jan; 66(1-2):29-37. PubMed ID: 15015767
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
19. In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors.
Ohe N; Saio M; Kijima M; Tamakawa N; Suwa T; Kojima Y; Yano H; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
Int J Oncol; 2003 Mar; 22(3):543-9. PubMed ID: 12579307
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.
Lettau I; Hattermann K; Held-Feindt J; Brauer R; Sedlacek R; Mentlein R
J Neuropathol Exp Neurol; 2010 Mar; 69(3):215-23. PubMed ID: 20142769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
